Hematology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Podcasts Q&As
Interactive
Polls Quizzes
Events & Education
ASH Annual Meeting

FDA Alerts

fda alert
fda
fda alert
FDA Approves Novel Treatment for Menopausal Hot Flashes
06/07/2023
Leigh Precopio
The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.
06/07/2023
fda alert
fda
fda alert
FDA Approves Novel Treatment for Menopausal Hot Flashes
06/07/2023
Leigh Precopio
The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.
06/07/2023
fda alert
fda
fda alert
FDA Approves Novel Treatment for Menopausal Hot Flashes
06/07/2023
Leigh Precopio
The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.
06/07/2023
FDA Alert
fda alert
FDA Alert
First Oral Treatment to Prevent Recurring Clostridioides difficile Infection Approved
06/01/2023
Jessica Ganga
The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.
06/01/2023
FDA Alert
fda alert
FDA Alert
First Oral Treatment to Prevent Recurring Clostridioides difficile Infection Approved
06/01/2023
Jessica Ganga
The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.
06/01/2023
FDA Alert
fda alert
FDA Alert
First Oral Treatment to Prevent Recurring Clostridioides difficile Infection Approved
06/01/2023
Jessica Ganga
The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.
06/01/2023
FDA Alert
fda alert
FDA Alert
First Oral Treatment to Prevent Recurring Clostridioides difficile Infection Approved
06/01/2023
Jessica Ganga
The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.
06/01/2023
FDA Alert
fda alert
FDA Alert
First Oral Treatment to Prevent Recurring Clostridioides difficile Infection Approved
06/01/2023
Jessica Ganga
The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.
06/01/2023
FDA Alert
fda
FDA Alert
FDA Approves First Prescription Nasal Spray to Reverse Opioid Overdose
05/27/2023
Jessica Ganga
The FDA’s approval of nalmefene hydrochloride nasal spray marks the first of its kind for health care and community use.
05/27/2023
FDA Alert
fda
FDA Alert
FDA Approves First Prescription Nasal Spray to Reverse Opioid Overdose
05/27/2023
Jessica Ganga
The FDA’s approval of nalmefene hydrochloride nasal spray marks the first of its kind for health care and community use.
05/27/2023